UK Statin Comments Mistake Prompts Transparent Consultation Reports
This article was originally published in The Tan Sheet
The UK Medicines & Healthcare products Regulatory Agency will now publicly post responses for all public switch consultations as part of a new transparency effort
You may also be interested in...
MHRA "inaccurately reported" the number of positive responses it received during a consultation period to switch Merck's Zocor Heart-Pro (simvastatin 10 mg) to nonprescription status in the UK, an article published in the Drug & Therapeutics Bulletin says
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning